Clinical/serological outcome in humans bitten by Babesia species positive Ixodes ricinus ticks in Sweden and on the Aland IslandsShow others and affiliations
2020 (English)In: Ticks and Tick-borne Diseases, ISSN 1877-959X, E-ISSN 1877-9603, Vol. 11, no 4, article id 101455Article in journal (Refereed) Published
Abstract [en]
The risk of contracting babesiosis after a tick bite in Sweden and on the Aland Islands, Finland, is unknown. We investigated clinical and serological outcomes in people bitten by Ixodes ricinus ticks positive for Babesia species. Ticks, blood and questionnaires were obtained from study participants in Sweden and on the Aland Islands. Sixty-five of 2098 (3.1 %) ticks were positive by real-time PCR. Three Babesia species were detected, Babesia microti (n = 33), B. venatorum (n = 27) and B. capreoli (n = 5), the latter species not known to cause human infection. Half (46 %) of the Babesia PCR-positive ticks also contained Borrelia spp. Fifty-three participants bitten by a Babesia PCR-positive tick and a control group bitten by a Babesia PCR-negative tick were tested for B. microti IgG antibodies by IFA. The overall seroprevalence was 4.4 %, but there was no significant difference between the groups. None of the participants seroconverted and no participant with a Babesia PCR-positive tick sought medical care or reported symptoms suggestive of babesiosis. Given the prevalence of Babesia in I. ricinus ticks in southern Sweden and on the Aland Islands, babesiosis should be considered a possible diagnosis in symptomatic residents who seek medical care following tick exposure.
Place, publisher, year, edition, pages
ELSEVIER GMBH , 2020. Vol. 11, no 4, article id 101455
Keywords [en]
Babesia; Babesiosis; Human; Seroconversion; Ixodes ricinus; Co-infection
National Category
Infectious Medicine
Identifiers
URN: urn:nbn:se:liu:diva-170172DOI: 10.1016/j.ttbdis.2020.101455ISI: 000567846500014PubMedID: 32386909OAI: oai:DiVA.org:liu-170172DiVA, id: diva2:1472175
Note
Funding Agencies|Swedish Research Council (Branch of Medicine)Swedish Research Council [K2008-58X-14631-06-3]; Medical Research Council of Southeast Sweden (FORSS) [657881]; Region Ostergotland; Interreg IVA Programme ScandTick; Interreg V OKS programme ScandTick Innovation; Wilhelm and Else Stockmann Foundation; Foundation for Aland Medical Research of the Aland Culture Foundation; North Sea Region programme, NorthTick [38-2-7-19]
2020-10-012020-10-012020-10-01